Single User License
INR 97605
Site License
INR 195210
Corporate User License
INR 292815

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Dicerna Pharmaceuticals, Inc.-Product Pipeline Review-2015

Dicerna Pharmaceuticals, Inc.-Product Pipeline Review-2015


  • Products Id :- GMDHC07493CDB
  • |
  • Pages: 39
  • |
  • August 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Dicerna Pharmaceuticals, Inc.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Dicerna Pharmaceuticals, Inc.-Product Pipeline Review-2015', provides an overview of the Dicerna Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Dicerna Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Dicerna Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Dicerna Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Dicerna Pharmaceuticals, Inc.'s pipeline products

Reasons To Buy

Evaluate Dicerna Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Dicerna Pharmaceuticals, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Dicerna Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Dicerna Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dicerna Pharmaceuticals, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Dicerna Pharmaceuticals, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Dicerna Pharmaceuticals, Inc. Snapshot 5

Dicerna Pharmaceuticals, Inc. Overview 5

Key Information 5

Key Facts 5

Dicerna Pharmaceuticals, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Dicerna Pharmaceuticals, Inc.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Pipeline Products-Out-Licensed Products 11

Out-Licensed Products/Combination Treatment Modalities 12

Dicerna Pharmaceuticals, Inc.-Pipeline Products Glance 13

Dicerna Pharmaceuticals, Inc.-Clinical Stage Pipeline Products 13

Phase I Products/Combination Treatment Modalities 13

Dicerna Pharmaceuticals, Inc.-Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Discovery Products/Combination Treatment Modalities 15

Dicerna Pharmaceuticals, Inc.-Drug Profiles 16

DCRM-1711 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Antisense RNAi Oligonucleotide to Inhibit BCAT for Solid tumors 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Antisense RNAi Oligonucleotide to Inhibit Beta Catenin for Oncology 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

DCRPH-1 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Antisense RNAi Oligonucleotide 2 for Rare Liver Diseases 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Antisense RNAi Oligonucleotide for Liver Fibrosis 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Antisense RNAi Oligonucleotides for Liver Diseases 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

RNAi Oligonucleotide for Alpha- Antitrypsin Deficiency and Liver Disease 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

RNAi Oligonucleotide for Clotting Disorder 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

RNAi Oligonucleotide for Rare Liver Diseases 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Dicerna Pharmaceuticals, Inc.-Pipeline Analysis 31

Dicerna Pharmaceuticals, Inc.-Pipeline Products by Target 31

Dicerna Pharmaceuticals, Inc.-Pipeline Products by Route of Administration 32

Dicerna Pharmaceuticals, Inc.-Pipeline Products by Molecule Type 33

Dicerna Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action 34

Dicerna Pharmaceuticals, Inc.-Recent Pipeline Updates 35

Dicerna Pharmaceuticals, Inc.-Locations And Subsidiaries 37

Head Office 37

Appendix 38

Methodology 38

Coverage 38

Secondary Research 38

Primary Research 38

Expert Panel Validation 38

Contact Us 38

Disclaimer 39

List of Tables

Dicerna Pharmaceuticals, Inc., Key Information 5

Dicerna Pharmaceuticals, Inc., Key Facts 5

Dicerna Pharmaceuticals, Inc.-Pipeline by Indication, 2015 8

Dicerna Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 9

Dicerna Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 10

Dicerna Pharmaceuticals, Inc.-Out-Licensed Products in Pipeline, 2015 11

Dicerna Pharmaceuticals, Inc.-Out-Licensed Products/ Combination Treatment Modalities, 2015 12

Dicerna Pharmaceuticals, Inc.-Phase I, 2015 13

Dicerna Pharmaceuticals, Inc.-Preclinical, 2015 14

Dicerna Pharmaceuticals, Inc.-Discovery, 2015 15

Dicerna Pharmaceuticals, Inc.-Pipeline by Target, 2015 31

Dicerna Pharmaceuticals, Inc.-Pipeline by Route of Administration, 2015 32

Dicerna Pharmaceuticals, Inc.-Pipeline by Molecule Type, 2015 33

Dicerna Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action, 2015 34

Dicerna Pharmaceuticals, Inc.-Recent Pipeline Updates, 2015 35

List of Figures

Dicerna Pharmaceuticals, Inc.-Pipeline by Top 10 Indication, 2015 7

Dicerna Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 9

Dicerna Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 10

Dicerna Pharmaceuticals, Inc.-Pipeline by Top 10 Target, 2015 31

Dicerna Pharmaceuticals, Inc.-Pipeline by Top 10 Route of Administration, 2015 32

Dicerna Pharmaceuticals, Inc.-Pipeline by Top 10 Molecule Type, 2015 33

Dicerna Pharmaceuticals, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Dicerna Pharmaceuticals, Inc.; Dicerna Pharmaceuticals, Inc. - Key Therapeutics; Dicerna Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Dicerna Pharmaceuticals, Inc. - News; Dicerna Pharmaceuticals, Inc. - Latest Updates; Dicerna Pharmaceuticals, Inc. - Pipeline; Dicerna Pharmaceuticals, Inc. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com